当前位置: 首页 >> 检索结果
2001. Pulmonary and extra-pulmonary effects of lung transplantation in an Italian cohort of patients with systemic sclerosis.
作者: Claudia Iannone.;Maria Rosa Pellico.;Letizia Corinna Morlacchi.;Valeria Rossetti.;Marco Vicenzi.;Lorenzo Beretta.;Adriana Severino.;Paolo Airò.;Fabio Cacciapaglia.;Veronica Codullo.;Paola Faggioli.;Annamaria Iagnocco.;Federica Meloni.;Lorena Mercante.;Marta Saracco.;Stefano Stano.;Eleonora Zaccara.;Antonina Minniti.;Silvia Cavalli.;Giorgia Trignani.;Francesco Blasi.;Mario Nosotti.;Massimo Boffini.;Roberto Caporali.;Nicoletta Del Papa.
来源: Rheumatology (Oxford). 2025年64卷SI期SI149-SI155页
Lung transplantation (LuTx) is a life-saving intervention for SSc patients with end-stage lung disease. The aim of this study was to evaluate patients' survival and LuTx outcomes on systemic disease manifestations.
2002. Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study.
作者: Till Uhlig.;Lars F Karoliussen.;Joe Sexton.;Sella A Provan.;Espen A Haavardsholm.;Nicola Dalbeth.;Hilde Berner Hammer.
来源: Rheumatology (Oxford). 2025年64卷4期1799-1806页
Patients with gout need to adhere to medication over time to achieve good outcomes. We assessed self-reported adherence to medication with urate lowering therapy (ULT) 5 years after a treat-to-target intervention and studied how non-adherence was related to baseline demographic and disease variables.
2003. Intestinal epithelial expression of human TNF is sufficient to induce small bowel inflammation and sacroiliitis, mimicking human spondyloarthritis.
作者: Karlijn Debusschere.;Donald Souza.;Gerald H Nabozny.;Emilie Dumas.;Eveline Verheugen.;Julie Coudenys.;Teddy Manuello.;Flore Stappers.;Tine Decruy.;Margaux Maelegheer.;Nadia Schryvers.;Elisabeth Gilis.;Dirk Elewaut.
来源: Rheumatology (Oxford). 2025年64卷5期3116-3124页
Gut and joint disease commonly co-occur in SpA. Up to 50% of patients with SpA show signs of subclinical gut inflammation, of which 10% develops IBD. However, the mechanisms underlying this gut-joint axis are still unclear. Here we investigated the hypothesis that restricted expression of a pro-inflammatory cytokine in the intestine may trigger the onset of combined gut and joint inflammation.
2005. Development and validation of a nomogram for predicting the interstitial fibrosis and tubular atrophy in patients with lupus nephritis.
作者: Huifang Wang.;Qiaoling Chen.;Qiuping Ye.;Lifang Liu.;Lixin Wei.
来源: Rheumatology (Oxford). 2025年64卷5期2647-2655页
Interstitial fibrosis and tubular atrophy (IFTA) were frequent histologic features of LN, and LN patients with IFTA have poor renal outcomes. In this study, we aimed to construct prediction models for the IFTA in LN patients.
2007. Erosion regression in patients with rheumatoid arthritis after upadacitinib-a pilot study using high resolution peripheral quantitative computed tomography.
作者: Ho So.;Isaac Cheng.;Evelyn Chow.;Qihan Wu.;Martin Li.;Vivian Hung.;Ling Qin.;Chun-Kwok Wong.;Lai-Shan Tam.
来源: Rheumatology (Oxford). 2025年64卷4期1723-1731页
To evaluate whether inhibition of Janus kinases (JAK) 1 could lead to erosion repair on high-resolution peripheral quantitative CT (HR-pQCT) in patients with active RA.
2008. Efficacy, safety and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry.
作者: Hidenori Sakai.;Yusuke Miyazaki.;Shingo Nakayamada.;Satoshi Kubo.;Kentaro Hanami.;Shunsuke Fukuyo.;Ayako Yamaguchi.;Ippei Miyagawa.;Masanobu Ueno.;Hiroaki Tanaka.;Yasuyuki Todoroki.;Naoaki Ohkubo.;Masashi Funada.;Satsuki Matsunaga.;Yoshiya Tanaka.
来源: Rheumatology (Oxford). 2025年64卷4期1930-1939页
This study investigated the efficacy, safety and predictive factors of belimumab (BEL) in induction therapy for patients with proliferative lupus nephritis (LN) in real-world settings.
2009. Fibroblast activation protein inhibitor positron emission tomography imaging in muscles of patients with idiopathic inflammatory myopathy.
作者: Yuying Zhang.;Bing Zhang.;Yuanyuan Niu.;Yali Long.;Qiao He.;Guangxi Luo.;Hanshi Xu.;Xiangsong Zhang.;Zhongping Zhan.;Dongying Chen.
来源: Rheumatology (Oxford). 2025年64卷4期2123-2132页
Mesenchymal stromal cells in muscles participate in regeneration following muscle injury. This study explored the potential of [18F]fibroblast activation protein inhibitor (FAPI)-42 PET targeting mesenchymal stromal cells to evaluate disease activity of idiopathic inflammatory myopathy (IIM).
2010. Validation of the International Myositis Assessment and Clinical Studies Group guideline on cancer risk stratification.
作者: Iris Yan Ki Tang.;Shirley Chiu Wai Chan.;Philip Hei Li.;Wai Ling Li.;Lucas Tsz Ho Luk.;Dennis Chan.;Roy Ho.;Billy Tin Lok Lai.;Patrick Man Leung Lee.;Vivian Hoi Shan Tang.;Ho So.
来源: Rheumatology (Oxford). 2025年64卷4期2106-2114页
Adult-onset idiopathic inflammatory myopathies (IIMs) are associated with cancer. Guideline on cancer risk stratifications and screening in IIM patients was recently published, but their external validity remains verified. We evaluated its applicability and reliability among a Hong Kong IIM cohort.
2011. Crystal-induced arthritis in prosthetic joints: a systematic review of clinical features, diagnosis, management, and outcomes.
作者: Haruki Sawada.;Jared Dang.;Bibek Saha.;Luke Taylor.;Yoshito Nishimura.;Melissa Kahili-Heede.;Cass Nakasone.;Sian Yik Lim.
来源: BMC Rheumatol. 2024年8卷1期43页
To summarize clinical presentations, baseline characteristics, diagnosis, treatment, and treatment outcomes through a systematic review of cases of crystal-induced arthritis in prosthetic joints in the literature.
2013. Ultrasonography-led multimodal diagnostic pathway for giant cell arteritis.
作者: Chetan B Mukhtyar.;Clare Beadsmoore.;Georgina Ducker.;Sarah Fordham.;Katherine Sisson.;Colin Jones.
来源: Rheumatology (Oxford). 2025年64卷4期2077-2082页
This study aims to establish the sensitivity and negative predictive value of a multimodal pathway incorporating ultrasonography, 18-fluorodeoxyglucose labelled PET-CT and temporal artery biopsy for the diagnosis of giant cell arteritis.
2014. Association between body weight and tocilizumab effectiveness in rheumatoid arthritis: results from the BSRBR-RA.
作者: Man Fung Tsoi.;Lianne Kearsley-Fleet.;Narges Azadbakht.;Kath Watson.;Kimme L Hyrich.;James Bluett.; .
来源: Rheumatology (Oxford). 2025年64卷2期477-483页
Tocilizumab is an IL-6 receptor humanized monoclonal antibody for the treatment of rheumatoid arthritis (RA) with intravenous (IV) and subcutaneous (SC) preparations available. Only IV tocilizumab is dosed adjusting for weight. Therefore, we aimed to study the association between body weight and the effectiveness of tocilizumab by the route of administration.
2015. Incidence and risk of arterial and venous thrombotic events in systemic lupus erythematosus patients: a population-based study.
作者: Luisa Ojeda-Fernandez.;Stefania Calvisi.;Ginevra Torrigiani.;Mauro Tettamanti.;Ida Fortino.;Carla Roncaglioni.;Marta Baviera.
来源: Rheumatology (Oxford). 2025年64卷5期2723-2730页
Current data on arterial and venous thrombotic events (ATE and VTE) and cardiovascular (CV) risk management in the European systemic lupus erythematosus (SLE) population are limited. This study aimed to investigate the incidence and risk of thrombotic events and all-cause death in an Italian SLE cohort over the past decade, along with its pharmacotherapy.
2016. Genetic risk, lifestyle adherence, and risk of developing hyperuricaemia in a Japanese population.
作者: Masato Takase.;Naoki Nakaya.;Tomohiro Nakamura.;Mana Kogure.;Rieko Hatanaka.;Kumi Nakaya.;Ippei Chiba.;Sayuri Tokioka.;Ikumi Kanno.;Kotaro Nochioka.;Naho Tsuchiya.;Takumi Hirata.;Akira Narita.;Taku Obara.;Mami Ishikuro.;Hisashi Ohseto.;Akira Uruno.;Tomoko Kobayashi.;Eiichi N Kodama.;Yohei Hamanaka.;Masatsugu Orui.;Soichi Ogishima.;Satoshi Nagaie.;Nobuo Fuse.;Junichi Sugawara.;Shinichi Kuriyama.;Koichi Matsuda.;Yoko Izumi.;Kengo Kinoshita.;Gen Tamiya.;Atsushi Hozawa.;Masayuki Yamamoto.; .
来源: Rheumatology (Oxford). 2025年64卷5期2591-2600页
The objective of this study was to investigate the inter-relationships among genetic risk, adherence to a healthy lifestyle, and susceptibility to hyperuricaemia.
2018. Novel deep-learning analysis for connective tissue disease-related interstitial lung disease extent assessment on CT: a preliminary cross-sectional study.
作者: Yuhei Ito.;Yasutaka Ichikawa.;Shuichi Murashima.;Hajime Sakuma.;Tae Iwasawa.;Yoshiyuki Arinuma.;Ayako Nakajima.
来源: Rheumatology (Oxford). 2025年64卷SI期SI14-SI20页
Physician's evaluation of interstitial lung disease (ILD) extension with high-resolution CT (HRCT) has limitations such as lack of objectivity and reproducibility. This study aimed to investigate the utility of computer-based deep-learning analysis using QZIP-ILD® software (DL-QZIP) compared with conventional approaches in CTD-related ILD.
2020. Imaging findings in cardiovascular involvements of IgG4-related disease: a systematic review study.
作者: Amir Ghaffari Jolfayi.;Alireza Salmanipour.;Kiyan Heshmat-Ghahdarijani.;Shahla Meshgi.;Maedeh Dastmardi.;Ghazaleh Salehabadi.;Amir Azimi.;Mohammad Hossein Mozafary Bazargany.;Peyvand Parhizkar Roudsari.;Behnaz Mahmoodiyeh.;Ali Mohammadzadeh.
来源: Rheumatology (Oxford). 2025年64卷3期943-951页
Immunoglobulin G4-related disease (IgG4-RD) is a fibroinflammatory condition characterized by IgG4-positive plasma cell infiltration that can affect multiple organs, including the cardiovascular system. The diagnosis of IgG4-RD relies on a combination of clinical, serological, radiological and pathological findings. However, due to the varied and insidious clinical presentations, normal IgG4 levels in a significant percentage of patients and frequent multi-organ involvement, imaging plays a crucial role in the diagnosis of IgG4-RD. The aim of this study is to comprehensively examine the imaging findings in IgG4-related cardiovascular disease for accurate diagnosis and appropriate treatment.
|